Statens Serum Institut

We strengthen health through disease control and research.

SSI has more than 100 years of experience in research, development and manufacturing of biologics.

SSI receives 18 million Euro from EDCTP to test malaria vaccines

4 October 2019

SSI receives 18 million Euro from EDCTP to test malaria vaccines

Read more

News

The number of new HIV diagnoses is declining

20 November 2019
If you are pregnant, you can now be vaccinated against whooping cough free of charge

20 November 2019
New insights into sex in Denmark

30 October 2019
Three researchers from Statens Serum Institut (SSI) each receives five million DKK from the Lundbeck Foundation

24 October 2019
Researcher at SSI chosen to establish new Center of Excellence for studies of inflammatory bowel diseases

23 October 2019

More News

More information

Vaccine Research

Vaccine Research

Vaccine research at Statens Serum Institut goes back to the institute’s founding in 1902, when it was set up to produce antisera for Diphtheria. Research soon expanded to other epidemic diseases. Today the main effort is devoted to vaccines against tuberculosis, chlamydia, HIV and novel adjuvants to direct and potentiate the immune responses.

Childhood vaccination programme

Childhood vaccination programme

Vaccinations are given by the local general practitioners who also give advice to the parents. There is no fee for vaccinations given to persons under 18 years of age.

Danish National Biobank

Danish National Biobank

The Danish National Biobank stores millions of samples available for use in specific research projects.

Antibodies

SSI Antibodies develops, produces and sells monoclonal and polyclonal antibodies as well as growth media additives and MBL standards worldwide.